298 related articles for article (PubMed ID: 11926892)
1. Diuretic therapy, the alpha-adducin gene variant, and the risk of myocardial infarction or stroke in persons with treated hypertension.
Psaty BM; Smith NL; Heckbert SR; Vos HL; Lemaitre RN; Reiner AP; Siscovick DS; Bis J; Lumley T; Longstreth WT; Rosendaal FR
JAMA; 2002 Apr; 287(13):1680-9. PubMed ID: 11926892
[TBL] [Abstract][Full Text] [Related]
2. Interaction between the Gly460Trp alpha-adducin gene variant and diuretics on the risk of myocardial infarction.
van Wieren-de Wijer DB; Maitland-van der Zee AH; de Boer A; Kroon AA; de Leeuw PW; Schiffers P; Janssen RG; Psaty BM; van Duijn CM; Stricker BH; Klungel OH
J Hypertens; 2009 Jan; 27(1):61-8. PubMed ID: 19145769
[TBL] [Abstract][Full Text] [Related]
3. Alpha-adducin polymorphism associated with increased risk of adverse cardiovascular outcomes: results from GENEtic Substudy of the INternational VErapamil SR-trandolapril STudy (INVEST-GENES).
Gerhard T; Gong Y; Beitelshees AL; Mao X; Lobmeyer MT; Cooper-DeHoff RM; Langaee TY; Schork NJ; Shriver MD; Pepine CJ; Johnson JA;
Am Heart J; 2008 Aug; 156(2):397-404. PubMed ID: 18657677
[TBL] [Abstract][Full Text] [Related]
4. Hormone replacement therapy, prothrombotic mutations, and the risk of incident nonfatal myocardial infarction in postmenopausal women.
Psaty BM; Smith NL; Lemaitre RN; Vos HL; Heckbert SR; LaCroix AZ; Rosendaal FR
JAMA; 2001 Feb; 285(7):906-13. PubMed ID: 11180734
[TBL] [Abstract][Full Text] [Related]
5. Angiotensinogen Met235Thr polymorphism, angiotensin-converting enzyme inhibitor therapy, and the risk of nonfatal stroke or myocardial infarction in hypertensive patients.
Bis JC; Smith NL; Psaty BM; Heckbert SR; Edwards KL; Lemaitre RN; Lumley T; Rosendaal FR
Am J Hypertens; 2003 Dec; 16(12):1011-7. PubMed ID: 14643574
[TBL] [Abstract][Full Text] [Related]
6. Alpha-adducin Gly460Trp variant increases the risk of stroke in hypertensive Dutch women.
Zafarmand MH; van der Schouw YT; Grobbee DE; de Leeuw PW; Bots ML
Hypertension; 2008 Jun; 51(6):1665-70. PubMed ID: 18458162
[TBL] [Abstract][Full Text] [Related]
7. Alpha Adducin (ADD1) Gene Polymorphism and New Onset of Diabetes Under the Influence of Selective Antihypertensive Therapy in Essential Hypertension.
Gupta S; Jhawat V; Agarwal BK; Roy P; Saini V
Curr Hypertens Rev; 2019; 15(2):123-134. PubMed ID: 30062972
[TBL] [Abstract][Full Text] [Related]
8. Alpha-adducin gene polymorphism and cardiovascular phenotypes in a general population.
Castellano M; Barlassina C; Muiesan ML; Beschi M; Cinelli A; Rossi F; Rizzoni D; Cusi D; Agabiti-Rosei E
J Hypertens; 1997 Dec; 15(12 Pt 2):1707-10. PubMed ID: 9488226
[TBL] [Abstract][Full Text] [Related]
9. Diuretic-gene interaction and the risk of myocardial infarction and stroke.
Schelleman H; Klungel OH; Witteman JC; Breteler MM; Hofman A; van Duijn CM; de Boer A; Stricker BH
Pharmacogenomics J; 2007 Oct; 7(5):346-52. PubMed ID: 17189961
[TBL] [Abstract][Full Text] [Related]
10. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group.
JAMA; 2000 Apr; 283(15):1967-75. PubMed ID: 10789664
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenetic association of the NPPA T2238C genetic variant with cardiovascular disease outcomes in patients with hypertension.
Lynch AI; Boerwinkle E; Davis BR; Ford CE; Eckfeldt JH; Leiendecker-Foster C; Arnett DK
JAMA; 2008 Jan; 299(3):296-307. PubMed ID: 18212314
[TBL] [Abstract][Full Text] [Related]
12. The role of alpha-adducin polymorphism in blood pressure and sodium handling regulation may not be excluded by a negative association study.
Glorioso N; Manunta P; Filigheddu F; Troffa C; Stella P; Barlassina C; Lombardi C; Soro A; Dettori F; Parpaglia PP; Alibrandi MT; Cusi D; Bianchi G
Hypertension; 1999 Oct; 34(4 Pt 1):649-54. PubMed ID: 10523341
[TBL] [Abstract][Full Text] [Related]
13. Antihypertensive therapy, the alpha-adducin polymorphism, and cardiovascular disease in high-risk hypertensive persons: the Genetics of Hypertension-Associated Treatment Study.
Davis BR; Arnett DK; Boerwinkle E; Ford CE; Leiendecker-Foster C; Miller MB; Black H; Eckfeldt JH
Pharmacogenomics J; 2007 Apr; 7(2):112-22. PubMed ID: 16702981
[TBL] [Abstract][Full Text] [Related]
14. beta1- and beta2-adrenergic receptor gene variation, beta-blocker use and risk of myocardial infarction and stroke.
Lemaitre RN; Heckbert SR; Sotoodehnia N; Bis JC; Smith NL; Marciante KD; Hindorff LA; Lange LA; Lumley TS; Rice KM; Wiggins KL; Psaty BM
Am J Hypertens; 2008 Mar; 21(3):290-6. PubMed ID: 18219297
[TBL] [Abstract][Full Text] [Related]
15. ACE and alpha-adducin polymorphism as markers of individual response to diuretic therapy.
Sciarrone MT; Stella P; Barlassina C; Manunta P; Lanzani C; Bianchi G; Cusi D
Hypertension; 2003 Mar; 41(3):398-403. PubMed ID: 12623934
[TBL] [Abstract][Full Text] [Related]
16. Alpha-adducin polymorphism, atherosclerosis, and cardiovascular and cerebrovascular risk.
van Rijn MJ; Bos MJ; Yazdanpanah M; Isaacs A; Arias-Vásquez A; Koudstaal PJ; Hofman A; Witteman JC; van Duijn CM; Breteler MM
Stroke; 2006 Dec; 37(12):2930-4. PubMed ID: 17082469
[TBL] [Abstract][Full Text] [Related]
17. Screening for the alpha-adducin Gly460Trp variant in hypertensive patients: a cost-effectiveness analysis.
Meckley LM; Veenstra DL
Pharmacogenet Genomics; 2006 Feb; 16(2):139-47. PubMed ID: 16424826
[TBL] [Abstract][Full Text] [Related]
18. The influence of the alpha-adducin G460W polymorphism and angiotensinogen M235T polymorphism on antihypertensive medication and blood pressure.
Schelleman H; Klungel OH; Witteman JC; Hofman A; van Duijn CM; de Boer A; Stricker BH
Eur J Hum Genet; 2006 Jul; 14(7):860-6. PubMed ID: 16724011
[TBL] [Abstract][Full Text] [Related]
19. The risk of myocardial infarction associated with antihypertensive drug therapies.
Psaty BM; Heckbert SR; Koepsell TD; Siscovick DS; Raghunathan TE; Weiss NS; Rosendaal FR; Lemaitre RN; Smith NL; Wahl PW
JAMA; 1995 Aug 23-30; 274(8):620-5. PubMed ID: 7637142
[TBL] [Abstract][Full Text] [Related]
20. Association between hypertension and variation in the alpha- and beta-adducin genes in a white population.
Wang JG; Staessen JA; Barlassina C; Fagard R; Kuznetsova T; Struijker-Boudier HA; Zagato L; Citterio L; Messaggio E; Bianchi G
Kidney Int; 2002 Dec; 62(6):2152-9. PubMed ID: 12427140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
